NAV

Light green SF yellowish

This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Generic Name
Light green SF yellowish
DrugBank Accession Number
DB11183
Background

Light green SF yellowish is a green triarylmethane dye that is used in the preparation of the staining solution which is widely used as a counterstain. It is used in histological applications and other labratory settings, and usually exists as a disodium salt. The maximum absorption of light green SF yellowish is at 630 (422) nm. Although it has been used as a food colorant, it was discontinued from the market due to low popularity which are possibly due to low durability of the dye and increased tendency of the dye to fade. Light green SF yellowish is also available as sterile strips used as a diagnostic agent when superficial corneal or conjunctival tissue change is suspected.

Type
Small Molecule
Groups
Approved, Experimental
Structure
Similar Structures
Weight
Average: 792.848
Monoisotopic: 792.122182116
Chemical Formula
C37H34N2Na2O9S3
Synonyms
  • A F Green No.2
  • A.F. Green No. 2
  • Acid Brilliant Green SF
  • Acid green
  • Acid green 5
  • Acid Green A
  • C.I. Acid Green 5
  • Lichtgruen
  • Light Green G
  • Light Green SF
  • Wool Brilliant Green SF
Poor quality drug data slowing you down?
Unlock 38% more drug discovery time and eliminate decision-making doubts with this one-stop guide to quality drug data.
Download eBook
Poor quality drug data slowing you down?
Download eBook

Pharmacology

Indication

Not Available

Reduce drug development failure rates
Build, train, & validate machine-learning models
with evidence-based and structured datasets.
See how
Build, train, & validate predictive machine-learning models with structured datasets.
See how
Contraindications & Blackbox Warnings
Prevent Adverse Drug Events Today
Tap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.
Learn more
Avoid life-threatening adverse drug events with our Clinical API
Learn more
Pharmacodynamics

Not Available

Mechanism of action
Not Available
Absorption

Not Available

Volume of distribution

Not Available

Protein binding

Not Available

Metabolism
Not Available
Route of elimination

Not Available

Half-life

Not Available

Clearance

Not Available

Adverse Effects
Improve decision support & research outcomes
With structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!
See the data
Improve decision support & research outcomes with our structured adverse effects data.
See a data sample
Toxicity

Not Available

Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Not Available
Food Interactions
No interactions found.

Products

Drug product information from 10+ global regions
Our datasets provide approved product information including:
dosage, form, labeller, route of administration, and marketing period.
Access now
Access drug product information from over 10 global regions.
Access now
Brand Name Prescription Products
NameDosageStrengthRouteLabellerMarketing StartMarketing EndRegionImage
GreenGloStrip1.5 mg/1.5mgOphthalmicHUB Pharmaceuticals, Inc.2012-04-01Not applicableUS flag
Unapproved/Other Products
NameIngredientsDosageRouteLabellerMarketing StartMarketing EndRegionImage
GreenGloLight green SF yellowish (1.5 mg/1.5mg)StripOphthalmicHUB Pharmaceuticals, Inc.2012-04-01Not applicableUS flag

Categories

Drug Categories
Chemical TaxonomyProvided by Classyfire
Description
This compound belongs to the class of organic compounds known as phenylbenzamines. These are aromatic compounds consisting of a benzyl group that is N-linked to a benzamine.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Phenylmethylamines
Direct Parent
Phenylbenzamines
Alternative Parents
Diphenylmethanes / Benzenesulfonic acids and derivatives / Benzenesulfonyl compounds / 1-sulfo,2-unsubstituted aromatic compounds / Dialkylarylamines / Benzylamines / Aniline and substituted anilines / Aralkylamines / Organosulfonic acids / Sulfonyls
show 7 more
Substituents
1-sulfo,2-unsubstituted aromatic compound / Amine / Aniline or substituted anilines / Aralkylamine / Aromatic homomonocyclic compound / Arylsulfonic acid or derivatives / Azomethine / Benzenesulfonate / Benzenesulfonyl group / Benzylamine
show 22 more
Molecular Framework
Aromatic homomonocyclic compounds
External Descriptors
organic sodium salt (CHEBI:87065)
Affected organisms
Not Available

Chemical Identifiers

UNII
3F7BHA64Z0
CAS number
5141-20-8
InChI Key
DGOBMKYRQHEFGQ-UHFFFAOYSA-L
InChI
InChI=1S/C37H36N2O9S3.2Na/c1-3-38(25-27-7-5-9-35(23-27)50(43,44)45)32-17-11-29(12-18-32)37(31-15-21-34(22-16-31)49(40,41)42)30-13-19-33(20-14-30)39(4-2)26-28-8-6-10-36(24-28)51(46,47)48;;/h5-24H,3-4,25-26H2,1-2H3,(H2-,40,41,42,43,44,45,46,47,48);;/q;2*+1/p-2
IUPAC Name
disodium 4-[(4-{ethyl[(3-sulfophenyl)methyl]amino}phenyl)[(1Z,4Z)-4-{ethyl[(3-sulfophenyl)methyl]iminiumyl}cyclohexa-2,5-dien-1-ylidene]methyl]benzene-1-sulfonate
SMILES
[Na+].[Na+].CCN(CC1=CC(=CC=C1)S([O-])(=O)=O)C1=CC=C(C=C1)C(C1=CC=C(C=C1)S([O-])(=O)=O)=C1C=CC(C=C1)=[N+](CC)CC1=CC(=CC=C1)S([O-])(=O)=O

References

General References
Not Available
PubChem Compound
21223
PubChem Substance
347827935
ChemSpider
19952
RxNav
1305579
ChEBI
87065

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage Forms
FormRouteStrength
StripOphthalmic1.5 mg/1.5mg
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility7.65e-05 mg/mLALOGPS
logP2.08ALOGPS
logP2.68Chemaxon
logS-7ALOGPS
pKa (Strongest Acidic)-2.3Chemaxon
pKa (Strongest Basic)3.52Chemaxon
Physiological Charge-2Chemaxon
Hydrogen Acceptor Count10Chemaxon
Hydrogen Donor Count0Chemaxon
Polar Surface Area177.85 Å2Chemaxon
Rotatable Bond Count12Chemaxon
Refractivity218.8 m3·mol-1Chemaxon
Polarizability77.18 Å3Chemaxon
Number of Rings5Chemaxon
Bioavailability0Chemaxon
Rule of FiveNoChemaxon
Ghose FilterNoChemaxon
Veber's RuleNoChemaxon
MDDR-like RuleYesChemaxon
Predicted ADMET Features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted GC-MS Spectrum - GC-MSPredicted GC-MSsplash10-000l-1000019300-04b04153c907756291f3
Chromatographic Properties
Collision Cross Sections (CCS)
AdductCCS Value (Å2)Source typeSource
[M-H]-313.5578319
predicted
DarkChem Lite v0.1.0
[M-H]-243.15558
predicted
DeepCCS 1.0 (2019)
[M+H]+312.4276319
predicted
DarkChem Lite v0.1.0
[M+H]+245.21788
predicted
DeepCCS 1.0 (2019)
[M+Na]+251.13042
predicted
DeepCCS 1.0 (2019)

Drug created at December 03, 2015 16:51 / Updated at June 12, 2020 16:53